Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende Patientenratgeber
Erweiterte Suche
Anmelden
nach oben
Digestive Diseases and Sciences
Erschienen in:

08.08.2017 | Review

The Clinical Implications of Fatty Pancreas: A Concise Review

verfasst von: Tawfik Khoury, Akwi W. Asombang, Tyler M. Berzin, Jonah Cohen, Douglas K. Pleskow, Meir Mizrahi

Erschienen in: Digestive Diseases and Sciences | Ausgabe 10/2017

Einloggen, um Zugang zu erhalten

Abstract

Fatty pancreas is a newly recognized condition which is poorly investigated until today as compared to nonalcoholic fatty liver disease. It is characterized by pancreatic fat accumulation and subsequent development of pancreatic and metabolic complications. Association of fatty pancreas have been described with type 2 diabetes mellitus, acute and chronic pancreatitis and even pancreatic carcinoma. In this review article, we provide an update on clinical implications, pathogenesis, diagnosis, treatment and outcomes.
Literatur
1.
Knight JA. Diseases and disorders associated with excess body weight. Ann Clin Lab Sci. 2011;41:107–121.PubMed
2.
Malecka-Tendera E, Mazur A. Childhood obesity: a pandemic of the twenty-first century. Int J Obes (Lond). 2006;30:S1–3.CrossRef
3.
Greenberg AS, Obin MS. Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr. 2006;83:461S–465S.PubMed
4.
Britton KA, Fox CS. Ectopic fat depots and cardiovascular disease. Circulation. 2011;124:e837–841.PubMedCrossRef
5.
Alisi A, Carpino G, Nobili V. Paediatric nonalcoholic fatty liver disease. Curr Opin Gastroenterol. 2013;29:279–284.PubMedCrossRef
6.
Fintini D, Chinali M, Cafiero G, et al. Early left ventricular abnormality/dysfunction in obese children affected by NAFLD. Nutr Metab Cardiovasc Dis. 2014;24:72–74.PubMedCrossRef
7.
Olsen TS. Lipomatosis of the pancreas in autopsy material and its relation to age and overweight. Acta Pathol Microbiol Scand A. 1978;86A:367–373.PubMed
8.
Lesmana CR, Pakasi LS, Inggriani S, Aidawati ML, Lesmana LA. Prevalence of nonalcoholic fatty pancreas disease (NAFPD) and its risk factors among adult medical check-up patients in a private hospital: a large cross sectional study. BMC Gastroenterol. 2015;15:174.PubMedPubMedCentralCrossRef
9.
Zhou J, Li ML, Zhang DD, et al. The correlation between pancreatic steatosis and metabolic syndrome in a Chinese population. Pancreatology. 2016;16:578–583.PubMedCrossRef
10.
Pham YH, Bingham BA, Bell CS, et al. Prevalence of pancreatic steatosis at a Pediatric Tertiary Care Center. South Med J. 2016;109:196–198.PubMedCrossRef
11.
Uygun A, Kadayifci A, Demirci H, et al. The effect of fatty pancreas on serum glucose parameters in patients with nonalcoholic steatohepatitis. Eur J Intern Med. 2015;26:37–41.PubMedCrossRef
12.
Al-Haddad M, Khashab M, Zyromski N, et al. Risk factors for hyperechogenic pancreas on endoscopic ultrasound: a case-control study. Pancreas. 2009;38:672–675.PubMedCrossRef
13.
Idilman IS, Tuzun A, Savas B, et al. Quantification of liver, pancreas, kidney, and vertebral body MRI-PDFF in nonalcoholic fatty liver disease. Abdom Imaging. 2015;40:1512–1519.PubMedCrossRef
14.
Dreiling DA, Elsbach P, Schaffner F, Schwartz IL. The effect of restriction of protein and total calories on pancreatic function in obese patients. Gastroenterology. 1962;42:686–690.PubMed
15.
Bradbury MW. Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: possible role in steatosis. Am J Physiol Gastrointest Liver Physiol. 2006;290:G194–198.PubMedCrossRef
16.
Patel AV, Rodriguez C, Bernstein L, Chao A, Thun MJ, Calle EE. Obesity, recreational physical activity, and risk of pancreatic cancer in a large U.S. Cohort. Cancer Epidemiol Biomark Prev. 2005;14:459–466.CrossRef
17.
Birt DF, Pelling JC, Nair S, Lepley D. Diet intervention for modifying cancer risk. Prog Clin Biol Res. 1996;395:223–234.PubMed
18.
Birt DF, Julius AD, White LT, Pour PM. Enhancement of pancreatic carcinogenesis in hamsters fed a high-fat diet ad libitum and at a controlled calorie intake. Cancer Res. 1989;49:5848–5851.PubMed
19.
van Raalte DH, van der Zijl NJ, Diamant M. Pancreatic steatosis in humans: Cause or marker of lipotoxicity? Curr Opin Clin Nutr Metab Care. 2010;13:478–485.PubMedCrossRef
20.
Zhao ZZ, Xin LL, Xia JH, Yang SL, Chen YX, Li K. Long-term high-fat high-sucrose diet promotes enlarged islets and beta-cell damage by oxidative stress in Bama Minipigs. Pancreas. 2015;44:888–895.PubMedCrossRef
21.
Fraulob JC, Ogg-Diamantino R, Fernandes-Santos C, Aguila MB, Mandarim-de-Lacerda CA. A mouse model of metabolic syndrome: insulin resistance, fatty liver and nonalcoholic fatty pancreas disease (NAFPD) in C57BL/6 mice fed a high fat diet. J Clin Biochem Nutr. 2010;46:212–223.PubMedPubMedCentralCrossRef
22.
Fernandes-Santos C, Evangelista Carneiro R, de Souza Mendonca L, Barbosa Aguila M, Mandarim-de-Lacerda CA. Rosiglitazone aggravates nonalcoholic fatty pancreatic disease in C57BL/6 mice fed high-fat and high-sucrose diet. Pancreas. 2009;38:e80–86.PubMedCrossRef
23.
Saisho Y, Butler AE, Meier JJ, et al. Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes. Clin Anat. 2007;20:933–942.PubMedPubMedCentralCrossRef
24.
Chai J, Liu P, Jin E, et al. MRI chemical shift imaging of the fat content of the pancreas and liver of patients with type 2 diabetes mellitus. Exp Ther Med. 2016;11:476–480.PubMedCrossRef
25.
Wang CY, Ou HY, Chen MF, Chang TC, Chang CJ. Enigmatic ectopic fat: prevalence of nonalcoholic fatty pancreas disease and its associated factors in a Chinese population. J Am Heart Assoc. 2014;3:e000297.PubMedPubMedCentralCrossRef
26.
Tushuizen ME, Bunck MC, Pouwels PJ, et al. Pancreatic fat content and beta-cell function in men with and without type 2 diabetes. Diabetes Care. 2007;30:2916–2921.PubMedCrossRef
27.
Della Corte C, Mosca A, Majo F, et al. Nonalcoholic fatty pancreas disease and nonalcoholic fatty liver disease: more than ectopic fat. Clin Endocrinol (Oxf). 2015;83:656–662.CrossRef
28.
van der Zijl NJ, Goossens GH, Moors CC, et al. Ectopic fat storage in the pancreas, liver, and abdominal fat depots: impact on beta-cell function in individuals with impaired glucose metabolism. J Clin Endocrinol Metab. 2011;96:459–467.PubMedCrossRef
29.
Chen DL, Liess C, Poljak A, et al. Phenotypic characterization of insulin-resistant and insulin-sensitive obesity. J Clin Endocrinol Metab. 2015;100:4082–4091.PubMedCrossRef
30.
Heni M, Machann J, Staiger H, et al. Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and/or impaired glucose tolerance: a nuclear magnetic resonance study. Diabetes Metab Res Rev. 2010;26:200–205.PubMedCrossRef
31.
32.
33.
Fullenkamp AM, Bell LN, Robbins RD, et al. Effect of different obesogenic diets on pancreatic histology in Ossabaw miniature swine. Pancreas. 2011;40:438–443.PubMedPubMedCentralCrossRef
34.
Lee JS, Kim SH, Jun DW, et al. Clinical implications of fatty pancreas: correlations between fatty pancreas and metabolic syndrome. World J Gastroenterol. 2009;15:1869–1875.PubMedPubMedCentralCrossRef
35.
Sepe PS, Ohri A, Sanaka S, et al. A prospective evaluation of fatty pancreas by using EUS. Gastrointest Endosc. 2011;73:987–993.PubMedCrossRef
36.
Kim MK, Chun HJ, Park JH, et al. The association between ectopic fat in the pancreas and subclinical atherosclerosis in type 2 diabetes. Diabetes Res Clin Pract. 2014;106:590–596.PubMedCrossRef
37.
Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640–1645.PubMedCrossRef
38.
Blomgren KB, Sundstrom A, Steineck G, Wiholm BE. Obesity and treatment of diabetes with glyburide may both be risk factors for acute pancreatitis. Diabetes Care. 2002;25:298–302.PubMedCrossRef
39.
Taguchi M, Kubo T, Yamamoto M, et al. Body mass index influences the outcome of acute pancreatitis: an analysis based on the Japanese administrative database. Pancreas. 2014;43:863–866.PubMedCrossRef
40.
Di Ciaula A, Portincasa P. Fat, epigenome and pancreatic diseases. Interplay and common pathways from a toxic and obesogenic environment. Eur J Intern Med. 2014;25:865–873.PubMedCrossRef
41.
Mathur A, Marine M, Lu D, et al. Nonalcoholic fatty pancreas disease. HPB (Oxford). 2007;9:312–318.CrossRef
42.
Zyromski NJ, Mathur A, Pitt HA, et al. A murine model of obesity implicates the adipokine milieu in the pathogenesis of severe acute pancreatitis. Am J Physiol Gastrointest Liver Physiol. 2008;295:G552–558.PubMedCrossRef
43.
Smits MM, van Geenen EJ. The clinical significance of pancreatic steatosis. Nat Rev Gastroenterol Hepatol. 2011;8:169–177.PubMedCrossRef
44.
Navina S, Acharya C, DeLany JP, et al. Lipotoxicity causes multisystem organ failure and exacerbates acute pancreatitis in obesity. Sci Transl Med. 2011;3:a110.CrossRef
45.
Patel K, Trivedi RN, Durgampudi C, et al. Lipolysis of visceral adipocyte triglyceride by pancreatic lipases converts mild acute pancreatitis to severe pancreatitis independent of necrosis and inflammation. Am J Pathol. 2015;185:808–819.PubMedPubMedCentralCrossRef
46.
Stolzenberg-Solomon RZ, Adams K, Leitzmann M, et al. Adiposity, physical activity, and pancreatic cancer in the National Institutes of Health-AARP Diet and Health Cohort. Am J Epidemiol. 2008;167:586–597.PubMedCrossRef
47.
Arslan AA, Helzlsouer KJ, Kooperberg C, et al. Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Arch Intern Med. 2010;170:791–802.PubMedPubMedCentralCrossRef
48.
Aune D, Greenwood DC, Chan DS, et al. Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose-response meta-analysis of prospective studies. Ann Oncol. 2012;23:843–852.PubMedCrossRef
49.
Michaud DS, Giovannucci E, Willett WC, Colditz GA, Stampfer MJ, Fuchs CS. Physical activity, obesity, height, and the risk of pancreatic cancer. JAMA. 2001;286:921–929.PubMedCrossRef
50.
Li D, Morris JS, Liu J, et al. Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. JAMA. 2009;301:2553–2562.PubMedPubMedCentralCrossRef
51.
Roberts DL, Dive C, Renehan AG. Biological mechanisms linking obesity and cancer risk: new perspectives. Annu Rev Med. 2010;61:301–316.PubMedCrossRef
52.
Matsuda M, Shimomura I. Increased oxidative stress in obesity: implications for metabolic syndrome, diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer. Obes Res Clin Pract. 2013;7:e330–341.PubMedCrossRef
53.
Hori M, Takahashi M, Hiraoka N, et al. Association of pancreatic fatty infiltration with pancreatic ductal adenocarcinoma. Clin Transl Gastroenterol. 2014;5:e53.PubMedPubMedCentralCrossRef
54.
Rebours V, Gaujoux S, d’Assignies G, et al. Obesity and fatty pancreatic infiltration are risk factors for pancreatic precancerous lesions (PanIN). Clin Cancer Res. 2015;21:3522–3528.PubMedCrossRef
55.
Mathur A, Zyromski NJ, Pitt HA, et al. Pancreatic steatosis promotes dissemination and lethality of pancreatic cancer. J Am Coll Surg. 2009;208:989–994. (discussion 994-986).PubMedCrossRef
56.
Khan NA, Amin MS, Islam MZ. Pancreatic lipomatosis with massive steatorrhea. Mymensingh Med J. 2011;20:712–714.PubMed
57.
Aubert A, Gornet JM, Hammel P, et al. Diffuse primary fat replacement of the pancreas: an unusual cause of steatorrhea. Gastroenterol Clin Biol. 2007;31:303–306.PubMedCrossRef
58.
59.
Gaujoux S, Cortes A, Couvelard A, et al. Fatty pancreas and increased body mass index are risk factors of pancreatic fistula after pancreaticoduodenectomy. Surgery. 2010;148:15–23.PubMedCrossRef
60.
Mathur A, Pitt HA, Marine M, et al. Fatty pancreas: a factor in postoperative pancreatic fistula. Ann Surg. 2007;246:1058–1064.PubMedCrossRef
61.
Robertson MB, Choe KA, Joseph PM. Review of the abdominal manifestations of cystic fibrosis in the adult patient. Radiographics. 2006;26:679–690.PubMedCrossRef
62.
Sodhi KS, Thapa BR, Khandelwal S, Suri S. Pancreatic lipomatosis in an infant with cystic fibrosis. Pediatr Radiol. 2005;35:1157–1158.PubMedCrossRef
63.
Feigelson J, Pecau Y, Poquet M, et al. Imaging changes in the pancreas in cystic fibrosis: a retrospective evaluation of 55 cases seen over a period of 9 years. J Pediatr Gastroenterol Nutr. 2000;30:145–151.PubMedCrossRef
64.
Johansson BB, Torsvik J, Bjorkhaug L, et al. Diabetes and pancreatic exocrine dysfunction due to mutations in the carboxyl ester lipase gene-maturity onset diabetes of the young (CEL-MODY): a protein misfolding disease. J Biol Chem. 2011;286:34593–34605.PubMedPubMedCentralCrossRef
65.
Raeder H, Haldorsen IS, Ersland L, et al. Pancreatic lipomatosis is a structural marker in nondiabetic children with mutations in carboxyl-ester lipase. Diabetes. 2007;56:444–449.PubMedCrossRef
66.
Takahashi T, Fujishima M, Tsuchida S, Enoki M, Takada G. Johanson-blizzard syndrome: loss of glucagon secretion response to insulin-induced hypoglycemia. J Pediatr Endocrinol Metab. 2004;17:1141–1144.PubMedCrossRef
67.
Zenker M, Mayerle J, Reis A, Lerch MM. Genetic basis and pancreatic biology of Johanson–Blizzard syndrome. Endocrinol Metab Clin North Am. 2006;35:243–253.PubMedCrossRef
68.
Alkhouri N, Kaplan B, Kay M, et al. Johanson–Blizzard syndrome with mild phenotypic features confirmed by UBR1 gene testing. World J Gastroenterol. 2008;14:6863–6866.PubMedPubMedCentralCrossRef
69.
Myers KC, Bolyard AA, Otto B, et al. Variable clinical presentation of Shwachman–Diamond syndrome: update from the North American Shwachman–Diamond syndrome registry. J Pediatr. 2014;164:866–870.PubMedCrossRef
70.
Ruggiero A, Molinari F, Coccia P, et al. MRI findings in Shwachman diamond syndrome. Pediatr Blood Cancer. 2008;50:352–354.PubMedCrossRef
71.
Lee JH, Bae SH, Yu JJ, Lee R, Yun YM, Song EY. A case of Shwachman–Diamond syndrome confirmed with genetic analysis in a Korean child. J Korean Med Sci. 2008;23:142–145.PubMedPubMedCentralCrossRef
72.
73.
Schmitz-Moormann P, Otte CA, Ihm P, Schmidt G. Comparative radiological and morphological study of the human pancreas. III. Morphometric investigation of the major pancreatic duct (author’s transl). Z Gastroenterol. 1979;17:256–263.PubMed
74.
Kolbel G, Majer MC, Hess CF, Kurtz B. The internal echo pattern of the normal pancreas. An assessment of the aging process and body weight dependence by sonographic gray-scale analysis. Rofo. 1987;146:415–419.PubMedCrossRef
75.
Marks WM, Filly RA, Callen PW. Ultrasonic evaluation of normal pancreatic echogenicity and its relationship to fat deposition. Radiology. 1980;137:475–479.PubMedCrossRef
76.
Glaser J, Stienecker K. Pancreas and aging: a study using ultrasonography. Gerontology. 2000;46:93–96.PubMedCrossRef
77.
Noronha M, Salgadinho A, Ferreira De Almeida MJ, Dreiling DA, Bordalo O. Alcohol and the pancreas. I. Clinical associations and histopathology of minimal pancreatic inflammation. Am J Gastroenterol. 1981;76:114–119.PubMed
78.
Musso G, Gambino R, Biroli G, et al. Hypoadiponectinemia predicts the severity of hepatic fibrosis and pancreatic Beta-cell dysfunction in nondiabetic nonobese patients with nonalcoholic steatohepatitis. Am J Gastroenterol. 2005;100:2438–2446.PubMedCrossRef
79.
80.
Liu L, Mei M, Yang S, Li Q. Roles of chronic low-grade inflammation in the development of ectopic fat deposition. Mediators Inflamm. 2014;2014:418185.PubMedPubMedCentral
81.
Tilg H. The role of cytokines in nonalcoholic fatty liver disease. Dig Dis. 2010;28:179–185.PubMedCrossRef
82.
Matsumoto S, Mori H, Miyake H, et al. Uneven fatty replacement of the pancreas: evaluation with CT. Radiology. 1995;194:453–458.PubMedCrossRef
83.
van Geenen EJ, Smits MM, Schreuder TC, van der Peet DL, Bloemena E, Mulder CJ. Nonalcoholic fatty liver disease is related to nonalcoholic fatty pancreas disease. Pancreas. 2010;39:1185–1190.PubMedCrossRef
84.
Zhang X, Cui Y, Fang L, Li F. Chronic high-fat diets induce oxide injuries and fibrogenesis of pancreatic cells in rats. Pancreas. 2008;37:e31–38.PubMedCrossRef
85.
Rosso E, Casnedi S, Pessaux P, et al. The role of “fatty pancreas” and of BMI in the occurrence of pancreatic fistula after pancreaticoduodenectomy. J Gastrointest Surg. 2009;13:1845–1851.PubMedCrossRef
86.
87.
Lee Y, Lingvay I, Szczepaniak LS, Ravazzola M, Orci L, Unger RH. Pancreatic steatosis: harbinger of type 2 diabetes in obese rodents. Int J Obes (Lond). 2010;34:396–400.CrossRef
88.
Itai Y, Saida Y, Kurosaki Y, Kurosaki A, Fujimoto T. Focal fatty masses of the pancreas. Acta Radiol. 1995;36:178–181.PubMedCrossRef
89.
Anand R, Narula MK, Chaudhary V, Agrawal R. Total pancreatic lipomatosis with malabsorption syndrome. Indian J Endocrinol Metab. 2011;15:51–53.PubMedPubMedCentralCrossRef
90.
Tranchart H, Gaujoux S, Rebours V, et al. Preoperative CT scan helps to predict the occurrence of severe pancreatic fistula after pancreaticoduodenectomy. Ann Surg. 2012;256:139–145.PubMedCrossRef
91.
Lim S, Bae JH, Chun EJ, et al. Differences in pancreatic volume, fat content, and fat density measured by multidetector-row computed tomography according to the duration of diabetes. Acta Diabetol. 2014;51:739–748.PubMedCrossRef
92.
Kim HJ, Byun JH, Park SH, et al. Focal fatty replacement of the pancreas: usefulness of chemical shift MRI AJR. Am J Roentgenol. 2007;188:429–432.CrossRef
93.
Hu HH, Kim HW, Nayak KS, Goran MI. Comparison of fat-water MRI and single-voxel MRS in the assessment of hepatic and pancreatic fat fractions in humans. Obesity (Silver Spring). 2010;18:841–847.CrossRef
94.
Hannukainen JC, Borra R, Linderborg K, et al. Liver and pancreatic fat content and metabolism in healthy monozygotic twins with discordant physical activity. J Hepatol. 2011;54:545–552.PubMedCrossRef
95.
Gaborit B, Abdesselam I, Kober F, et al. Ectopic fat storage in the pancreas using 1H-MRS: importance of diabetic status and modulation with bariatric surgery-induced weight loss. Int J Obes (Lond). 2015;39:480–487.CrossRef
96.
Yu H, Shimakawa A, McKenzie CA, Brodsky E, Brittain JH, Reeder SB. Multiecho water-fat separation and simultaneous R2* estimation with multifrequency fat spectrum modeling. Magn Reson Med. 2008;60:1122–1134.PubMedPubMedCentralCrossRef
97.
Reeder SB, Hu HH, Sirlin CB. Proton density fat-fraction: a standardized MR-based biomarker of tissue fat concentration. J Magn Reson Imaging. 2012;36:1011–1014.PubMedPubMedCentralCrossRef
98.
Meisamy S, Hines CD, Hamilton G, et al. Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy. Radiology. 2011;258:767–775.PubMedPubMedCentralCrossRef
99.
Yokoo T, Shiehmorteza M, Hamilton G, et al. Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T. Radiology. 2011;258:749–759.PubMedPubMedCentralCrossRef
100.
Au WY, Lam WW, Chu W, et al. A T2* magnetic resonance imaging study of pancreatic iron overload in thalassemia major. Haematologica. 2008;93:116–119.PubMedCrossRef
101.
Noetzli LJ, Papudesi J, Coates TD, Wood JC. Pancreatic iron loading predicts cardiac iron loading in thalassemia major. Blood. 2009;114:4021–4026.PubMedPubMedCentralCrossRef
102.
Beckonert O, Keun HC, Ebbels TM, et al. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc. 2007;2:2692–2703.PubMedCrossRef
103.
Moestue S, Sitter B, Bathen TF, Tessem MB, Gribbestad IS. HR MAS MR spectroscopy in metabolic characterization of cancer. Curr Top Med Chem. 2011;11:2–26.PubMedCrossRef
104.
105.
Edens MA, van Ooijen PM, Post WJ, et al. Ultrasonography to quantify hepatic fat content: validation by 1H magnetic resonance spectroscopy. Obesity (Silver Spring). 2009;17:2239–2244.CrossRef
106.
Uchida H, Hirooka Y, Itoh A, et al. Feasibility of tissue elastography using transcutaneous ultrasonography for the diagnosis of pancreatic diseases. Pancreas. 2009;38:17–22.PubMedCrossRef
107.
108.
Hirooka Y, Kuwahara T, Irisawa A, et al. JSUM ultrasound elastography practice guidelines: pancreas. J Med Ultrason. 2001;2015:151–174.
109.
Honka H, Koffert J, Hannukainen JC, et al. The effects of bariatric surgery on pancreatic lipid metabolism and blood flow. J Clin Endocrinol Metab. 2015;100:2015–2023.PubMedCrossRef
110.
Souza-Mello V, Gregorio BM, Relvas-Lucas B, da Silva Faria T, Aguila MB, Mandarim-de-Lacerda CA. Pancreatic ultrastructural enhancement due to telmisartan plus sitagliptin treatment in diet-induced obese C57BL/6 mice. Pancreas. 2011;40:715–722.PubMedCrossRef
111.
Jia DM, Fukumitsu KI, Tabaru A, Akiyama T, Otsuki M. Troglitazone stimulates pancreatic growth in congenitally CCK-A receptor-deficient OLETF rats. Am J Physiol Regul Integr Comp Physiol. 2001;280:R1332–1340.PubMed
112.
Zhao L, Jiang SJ, Lu FE, et al. Effects of berberine and cinnamic acid on palmitic acid-induced intracellular triglyceride accumulation in NIT-1 pancreatic beta cells. Chin J Integr Med. 2016;22:496–502.PubMedCrossRef
Metadaten
Titel
The Clinical Implications of Fatty Pancreas: A Concise Review
verfasst von
Tawfik Khoury
Akwi W. Asombang
Tyler M. Berzin
Jonah Cohen
Douglas K. Pleskow
Meir Mizrahi
Publikationsdatum
08.08.2017
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 10/2017
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-017-4700-1

Weitere Artikel der Ausgabe 10/2017

Perceptions of the Inpatient Training Experience: A Nationwide Survey of Gastroenterology Program Directors and Fellows

  • Fellows and Young Gis Section

Usefulness of Non-magnifying Narrow Band Imaging in EVIS EXERA III Video Systems and High-Definition Endoscopes to Diagnose Dysplasia in Barrett’s Esophagus Using the Barrett International NBI Group (BING) Classification

  • Original Article

Obstructive Sleep Apnea Increases the Risk of Cardiopulmonary Adverse Events Associated with Ambulatory Colonoscopy Independent of Body Mass Index

  • Original Article

Early Abdominal Imaging Remains Over-Utilized in Acute Pancreatitis

  • Original Article

Erratum to: Repeat Rifaximin for Irritable Bowel Syndrome: No Clinically Significant Changes in Stool Microbial Antibiotic Sensitivity

  • Erratum

Treatment Response and Outcome with Two Different Prednisolone Regimens in Autoimmune Hepatitis

  • Original Article

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Verbände und Cremes gegen Dekubitus: „Wir wissen nicht, was sie bringen!“

Die Datenlage zur Wirksamkeit von Verbänden oder topischen Mitteln zur Prävention von Druckgeschwüren sei schlecht, so die Verfasser einer aktuellen Cochrane-Studie. Letztlich bleibe es unsicher, ob solche Maßnahmen den Betroffenen nutzen oder schaden.

Schützt das tägliche Glas Milch vor Darmkrebs?

Die Milch machts – sie bietet Frauen nach Daten einer großen Ernährungsanalyse den besten Darmkrebsschutz aller Lebensmittel, was am hohen Kalziumgehalt liegen dürfte. Am anderen Ende des Spektrums steht der Alkoholkonsum: Das Glas Wein am Abend ist eher ungünstig.

Vorsicht mit Glukokortikoiden bei Glomerulopathie

Auch niedrig dosierte Glukokortikoide zur Behandlung einer primären Glomerulopathie lassen offenbar die Infektionsgefahr steigen. In einer US-Studie hing das Risiko vor allem mit der kombinierten Anwendung von Immunsuppressiva zusammen.

KI-gestütztes Mammografiescreening überzeugt im Praxistest

Mit dem Einsatz künstlicher Intelligenz lässt sich die Detektionsrate im Mammografiescreening offenbar deutlich steigern. Mehr unnötige Zusatzuntersuchungen sind laut der Studie aus Deutschland nicht zu befürchten.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Jetzt 10 CME-Punkte sammeln

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise